[New trends in antineoplastic drug research].
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016190:Carboplatin; D003613:Danazol / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D005492:Folic Acid / Q000031:analogs & derivatives*; D006248:Harringtonines / Q000627:therapeutic use; D006801:Humans; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D013942:Thymine Nucleotides / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D006248:Harringtonines; D009944:Organoplatinum Compounds; D011799:Quinazolines; D013942:Thymine Nucleotides; C031662:CB 3717; D005492:Folic Acid; D016190:Carboplatin; D003613:Danazol; D005472:Fluorouracil